Manchester Capital Management’s Eli Lilly LLY Stock Holding History

Manchester Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.55M	Buy	3,864 +24	+0.6%	+$24.3K	0.51%	31
2025 Q4	$4.13M	Buy	3,840 +274	+8%	+$262K	0.56%	28
2025 Q3	$2.72M	Sell	3,566 -1,445	-29%	-$1.08M	0.37%	43
2025 Q2	$3.91M	Sell	5,011 -14	-0.3%	-$10.9K	0.51%	32
2025 Q1	$4.15M	Sell	5,025 -491	-9%	-$409K	0.51%	37
2024 Q4	$4.26M	Buy	5,516 +812	+17%	+$672K	0.49%	37
2024 Q3	$4.17M	Buy	4,704 +538	+13%	+$484K	0.49%	38
2024 Q2	$3.77M	Buy	4,166 +117	+3%	+$93.6K	0.45%	39
2024 Q1	$3.15M	Buy	4,049 +1,025	+34%	+$729K	0.39%	43
2023 Q4	$1.76M	Buy	3,024 +147	+5%	+$85.8K	0.24%	66
2023 Q3	$1.55M	Buy	2,877 +199	+7%	+$103K	0.23%	66
2023 Q2	$1.26M	Buy	2,678 +817	+44%	+$343K	0.17%	82
2023 Q1	$639K	Sell	1,861 -3	-0.2%	-$1.01K	0.08%	152
2022 Q4	$682K	Hold	1,864	–	–	0.1%	120
2022 Q3	$603K	Sell	1,864 -1	-0.1%	-$317	0.11%	107
2022 Q2	$605K	Buy	1,865 +911	+95%	+$273K	0.1%	112
2022 Q1	$273K	Sell	954 -50	-5%	-$12.9K	0.04%	217
2021 Q4	$277K	Buy	1,004 +23	+2%	+$5.83K	0.04%	229
2021 Q3	$227K	Buy	981 +22	+2%	+$5.43K	0.03%	263
2021 Q2	$220K	Buy	959 +9	+0.9%	+$1.81K	0.03%	252
2021 Q1	$177K	Sell	950 -9	-0.9%	-$1.76K	0.03%	268
2020 Q4	$162K	Buy	959 +7	+0.7%	+$1.04K	0.03%	259
2020 Q3	$141K	Sell	952 -1,258	-57%	-$195K	0.02%	247
2020 Q2	$363K	Hold	2,210	–	–	0.05%	177
2020 Q1	$307K	Hold	2,210	–	–	0.05%	178
2019 Q4	$290K	Hold	2,210	–	–	0.03%	216
2019 Q3	$247K	Sell	2,210 -260	-11%	-$28.9K	0.03%	217
2019 Q2	$274K	Hold	2,470	–	–	0.04%	211
2019 Q1	$321K	Hold	2,470	–	–	0.04%	185
2018 Q4	$211K	Hold	2,470	–	–	0.03%	209
2018 Q3	$265K	Hold	2,470	–	–	0.04%	195
2018 Q2	$211K	Hold	2,470	–	–	0.03%	212
2018 Q1	$191K	Buy	2,470 +260	+12%	+$20.9K	0.03%	208
2017 Q4	$187K	Buy	2,210 +50	+2%	+$4.25K	0.03%	205
2017 Q3	$185K	Hold	2,160	–	–	0.03%	192
2017 Q2	$178K	Hold	2,160	–	–	0.03%	207
2017 Q1	$182K	Hold	2,160	–	–	0.03%	203
2016 Q4	$159K	Hold	2,160	–	–	0.02%	207
2016 Q3	$173K	Hold	2,160	–	–	0.03%	210
2016 Q2	$170K	Hold	2,160	–	–	0.02%	212
2016 Q1	$156K	Hold	2,160	–	–	0.02%	227
2015 Q4	$182K	Hold	2,160	–	–	0.03%	223
2015 Q3	$181K	Hold	2,160	–	–	0.03%	213
2015 Q2	$180K	Hold	2,160	–	–	0.03%	218
2015 Q1	$156K	Sell	2,160 -903	-29%	-$64.3K	0.02%	230
2014 Q4	$211K	Hold	3,063	–	–	0.03%	343
2014 Q3	$199K	Sell	3,063 -2,000	-40%	-$127K	0.03%	345
2014 Q2	$315K	Buy	5,063 +103	+2%	+$6.14K	0.04%	255
2014 Q1	$292K	Buy	4,960 +2,000	+68%	+$112K	0.05%	243
2013 Q4	$151K	Buy	2,960 +132	+5%	+$6.61K	0.02%	400
2013 Q3	$142K	Sell	2,828 -106	-4%	-$5.55K	0.02%	399
2013 Q2	$144K	Buy	+2,934	New	+$160K	0.03%	386

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Manchester Capital Management's LLY Position: Q1 2026 in Review

Manchester Capital Management increased its Eli Lilly (LLY) stake by 0.63% in Q1 2026, buying an estimated $24.3K and bringing the position to 3,864 shares worth $3.55M. The position accounts for 0.51% of the portfolio, ranked #31.

Manchester Capital Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.26M in Q4 2024. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Manchester Capital Management held 3,864 shares of Eli Lilly worth $3.55M as of Q1 2026.
Manchester Capital Management bought 24 Eli Lilly shares in Q1 2026, an estimated $24.3K.
Eli Lilly made up 0.51% of Manchester Capital Management's portfolio in Q1 2026, its #31 holding.
Manchester Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
Manchester Capital Management's Eli Lilly position peaked at $4.26M in Q4 2024.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.